Cite
HARVARD Citation
Rubin, D. et al. (n.d.). MIRIKIZUMAB IMPROVES PATIENT ASSESSMENT OF DISEASE SEVERITY AND CHANGE IN DISEASE ACTIVITY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE. Inflammatory bowel diseases. pp. S14-S15. [Online].